The State of Texas Attorney General Files Lawsuit Against Acetaminophen Manufacturers Over Autism Claims

Judicial Proceedings
Ken Paxton, who supports former President Trump who is running for the United States Senate, accused pharmaceutical manufacturers of concealing potential dangers of acetaminophen

Texas Attorney General Paxton is filing a lawsuit against the makers of Tylenol, claiming the firms withheld safety concerns that the drug presented to pediatric cognitive development.

The lawsuit follows a month after Donald Trump promoted an unverified association between taking Tylenol - also known as paracetamol - while pregnant and autism in young ones.

Paxton is taking legal action against J&J, which previously sold the medication, the only pain reliever recommended for pregnant women, and Kenvue, which presently makes it.

In a official comment, he claimed they "deceived the public by gaining financially from discomfort and promoting medication regardless of the potential hazards."

Kenvue asserts there is lacking scientific proof tying acetaminophen to autism.

"These companies misled for generations, intentionally threatening numerous people to line their pockets," Paxton, a Republican, declared.

Kenvue stated officially that it was "very worried by the perpetuation of misinformation on the safety of acetaminophen and the potential impact that could have on the health of US mothers and children."

On its online platform, the company also mentioned it had "continuously evaluated the pertinent research and there is no credible data that shows a verified association between using paracetamol and autism."

Organizations acting on behalf of doctors and healthcare providers share this view.

The leading OB-GYN organization has declared acetaminophen - the main ingredient in acetaminophen - is among limited choices for women during pregnancy to treat discomfort and elevated temperature, which can pose significant medical dangers if left untreated.

"In over twenty years of research on the consumption of acetaminophen in gestation, zero credible investigations has successfully concluded that the consumption of paracetamol in any trimester of pregnancy causes neurodevelopmental disorders in children," the organization commented.

The court filing mentions recent announcements from the previous government in arguing the drug is potentially dangerous.

Last month, the former president generated worry from medical authorities when he told pregnant women to "fight like hell" not to take acetaminophen when sick.

The FDA then published an announcement that physicians should consider limiting the usage of acetaminophen, while also mentioning that "a direct connection" between the drug and autism in minors has remains unverified.

The Health Department head RFK Jr, who supervises the Food and Drug Administration, had promised in April to undertake "extensive scientific investigation" that would identify the cause of autism in a limited time.

But authorities warned that discovering a unique factor of autism - believed by scientists to be the result of a intricate combination of genetic and surrounding conditions - would prove challenging.

Autism spectrum disorder is a type of lifelong neurodivergence and condition that influences how individuals perceive and engage with the environment, and is recognized using medical professional evaluations.

In his lawsuit, Paxton - a Trump ally who is campaigning for US Senate - claims Kenvue and Johnson & Johnson "intentionally overlooked and tried to quiet the evidence" around acetaminophen and autism.

This legal action seeks to make the firms "eliminate any commercial messaging" that states Tylenol is safe for women during pregnancy.

The court case parallels the grievances of a collection of mothers and fathers of children with autism and ADHD who took legal action against the producers of Tylenol in 2022.

The court rejected the lawsuit, stating studies from the plaintiffs' authorities was not conclusive.

John Johnson
John Johnson

A seasoned digital strategist passionate about helping creators thrive in the evolving online landscape.